Synovial Chondrosarcoma: a Single Institution Experience

Completed

• Conditions: Synovial Chondrosarcoma

• Registration Number: NCT03776942
• Lead Sponsor: Istituto Ortopedico Rizzoli

Brief Summary

single institution cases series review of histological, radiological and clinical data

Detailed Description

single institution cases series review of histological, radiological and clinical data. Investigators will retrieve from the archives of the Rizzoli institute all the cases with a histological diagnosis of synovial chondrosarcoma.

Study Timeline

• Study Start: 2018-08-07
• Status Verified: 2018-12
• Primary Completion: 2018-12-01
• Study First Submitted: 2018-12-10
• Study First Submitted QC: 2018-12-13
• Study First Posted: 2018-12-17
• Study Completion: 2019-08-31
• Last Update Submitted: 2020-02-11
• Last Update Posted: 2020-02-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 9

Inclusion Criteria

• Male and female patients treated at Rizzoli Institute from 01 January 1982 to 31 December 2017
• Diagnosis of synovial chondrosarcoma
• Age ≥ 18 years
• Histological slides / formalin-fixed paraffin-embedded tissue tumor (FFPE) blocks from archive available to perform the histology analysis
• Written informed consent prior to any study-specific analysis and/or data collection

Exclusion Criteria

• Patients with histological diagnosis different from synovial chondrosarcoma

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
selection and review of cases of Synovial Chondrosarcoma	baseline (Day0)	IDH1 and IDH2 analysis will be performed in order to better understand tumor characteristics and to identify the best therapeutic approach.

Trial Locations

Locations (1)

IRCC Rizzoli Orthopedic Institute; 🇮🇹 Bologna, Italy